These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 31936832)

  • 1. Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer.
    Mukherjee A; Madamsetty VS; Paul MK; Mukherjee S
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of Biomolecular Nanostructures for Anti-Angiogenic Theranostics.
    Canlas KKV; Park H
    Int J Nanomedicine; 2024; 19():6485-6497. PubMed ID: 38946886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic application of anti-angiogenic nanomaterials in cancers.
    Mukherjee S; Patra CR
    Nanoscale; 2016 Jul; 8(25):12444-70. PubMed ID: 27067119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered Nanoparticles for Effective Redox Signaling During Angiogenic and Antiangiogenic Therapy.
    Nethi SK; Barui AK; Mukherjee S; Patra CR
    Antioxid Redox Signal; 2019 Feb; 30(5):786-809. PubMed ID: 29943661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective treatment of intractable diseases using nanoparticles to interfere with vascular supply and angiogenic process.
    Hoseinzadeh A; Ghoddusi Johari H; Anbardar MH; Tayebi L; Vafa E; Abbasi M; Vaez A; Golchin A; Amani AM; Jangjou A
    Eur J Med Res; 2022 Nov; 27(1):232. PubMed ID: 36333816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotherapeutic approaches targeting angiogenesis and immune dysfunction in tumor microenvironment.
    Hameed S; Bhattarai P; Dai Z
    Sci China Life Sci; 2018 Apr; 61(4):380-391. PubMed ID: 29607461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomaterials for Antiangiogenic Therapies for Cancer: A Promising Tool for Personalized Medicine.
    Alsaab HO; Al-Hibs AS; Alzhrani R; Alrabighi KK; Alqathama A; Alwithenani A; Almalki AH; Althobaiti YS
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles.
    Jiang W; Huang Y; An Y; Kim BY
    ACS Nano; 2015 Sep; 9(9):8689-96. PubMed ID: 26212564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic Targets for Glioblastoma Therapy from a Pre-Clinical Approach, Using Nanoformulations.
    Nery de Albuquerque Rego G; da Hora Alves A; Penteado Nucci M; Bustamante Mamani J; Anselmo de Oliveira F; Gamarra LF
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nano-targeting vascular remodeling in cancer: Recent developments and future directions.
    Giordo R; Wehbe Z; Paliogiannis P; Eid AH; Mangoni AA; Pintus G
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):784-804. PubMed ID: 35257860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic therapeutic strategies and engineered nanoparticles for anti-vascular endothelial growth factor therapy in cancer.
    Khafaga AF; Gaballa MMS; Karam R; Shoulah SA; Shamma RN; Khalifa NE; Farrag NE; Noreldin AE
    Life Sci; 2024 Mar; 341():122499. PubMed ID: 38342375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Developments in Anti-Angiogenic Therapy of Cancer, Review and Update.
    Ghasemali S; Farajnia S; Barzegar A; Rahmati-Yamchi M; Baghban R; Rahbarnia L; Nodeh HRY
    Anticancer Agents Med Chem; 2021; 21(1):3-19. PubMed ID: 32807068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive Nanotherapeutic Ultrasound Contrast Agent for Concurrent Breast Cancer Ultrasound Imaging and Treatment.
    Fang J; Tan J; Lin L; Cao Y; Xu R; Lin C; He G; Xu X; Xiao X; Jiang Q; Saw PE
    Adv Healthc Mater; 2024 Oct; 13(26):e2401436. PubMed ID: 38923231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnological strategies for therapeutic targeting of tumor vasculature.
    Ding Y; Li S; Nie G
    Nanomedicine (Lond); 2013 Jul; 8(7):1209-22. PubMed ID: 23837858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis in cancer: molecular mechanisms, clinical impact.
    Eichhorn ME; Kleespies A; Angele MK; Jauch KW; Bruns CJ
    Langenbecks Arch Surg; 2007 May; 392(3):371-9. PubMed ID: 17458577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Nanomedicine for Ocular Fundus Neovascularization Disease Management.
    Zhou Y; Xu M; Shen W; Xu Y; Shao A; Xu P; Yao K; Han H; Ye J
    Adv Healthc Mater; 2024 Jul; 13(17):e2304626. PubMed ID: 38406994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor vasculature-targeting nanomedicines.
    Zhang Y; He J
    Acta Biomater; 2021 Oct; 134():1-12. PubMed ID: 34271167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid Nanoplatforms Comprising Organic Nanocompartments Encapsulating Inorganic Nanoparticles for Enhanced Drug Delivery and Bioimaging Applications.
    Yanar F; Carugo D; Zhang X
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.